(Q36278312)

13 August 2017

1 reference

title

Natural health product interactions with medication (English)

1 reference

13 August 2017

Joseph Boullata

1

1 reference

13 August 2017

publication date

1 February 2005

1 reference

Nutrition in Clinical Practice

13 August 2017

published in

1 reference

13 August 2017

volume

20

1 reference

13 August 2017

issue

1

1 reference

13 August 2017

page(s)

33-51

1 reference

Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Drug-nutrient interaction in clinical nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Health risks of herbal remedies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Nutraceuticals: a pharmaceutical viewpoint: I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Quality, efficacy and safety of complementary medicines: fashions, facts and the future. Part II: Efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

21 January 2018

Herb-drug interactions

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Interactions between herbal medicines and prescribed drugs: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Herb-drug interactions: review and assessment of report reliability

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Herb-drug, food-drug, nutrient-drug, and drug-drug interactions: mechanisms involved and their medical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Drug interactions between herbal and prescription medicines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Drug interactions update: drugs, herbs, and oral anticoagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Herbal medication: potential for adverse interactions with analgesic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

The importance of drug interactions in epilepsy therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Serious psychiatric and neurological adverse effects of herbal medicines -- a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Herbal remedies, dietary supplements, and seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Use of herbal medicines by patients receiving warfarin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Herbal medicine: potential for intoxication and interactions with conventional drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

The Pharmacokinetics of Linezolid Are Not Affected by Concomitant Intake of the Antioxidant Vitamins C and E

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

The effect of oral iron admiinistration on mycophenolate mofetil absorption in renal transplant recipients: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Use of complementary and alternative medical therapies in patients with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Herbal products and conventional medicines used by community-residing older women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Potential interactions between herbal medicines and conventional drug therapies used by older adults attending a memory clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Herbal therapy use in a pediatric emergency department population: expect the unexpected

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Interactions of a herbal combination that inhibits growth of prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Clinical pharmacokinetics of iron preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Absorption of slow-release iron and effects of ascorbic acid in normal subjects and after partial gastrectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Emerging role of riboflavin in the treatment of nucleoside analogue-induced type B lactic acidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Effect of folic acid on fenofibrate-induced elevation of homocysteine and cysteine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Folate supplementation and methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Integration of herbal medicine into modern medical practices: issues and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Quality, efficacy and safety of complementary medicines: fashions, facts and the future. Part I. Regulation and quality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Herb-drug interactions: survey of leading pharmaceutical/herbal companies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Interactions of warfarin with garlic, ginger, ginkgo, or ginseng: nature of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Ginger-associated overanticoagulation by phenprocoumon

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Bosentan and warfarin interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Drug-herb interaction among commonly used conventional medicines: a compendium for health care professionals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Effect of age on international normalized ratio at the time of major bleeding in patients treated with warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Interactions of herbs with cytochrome P450.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Insights into the structure and substrate interactions of the P-glycoprotein multidrug transporter from spectroscopic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Interaction of combinations of drugs, chemosensitizers, and peptides with the P-glycoprotein multidrug transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Combined phenotypic assessment of cytochrome p450 1A2, 2C9, 2C19, 2D6, and 3A, N-acetyltransferase-2, and xanthine oxidase activities with the "Cooperstown 5+1 cocktail".

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

An approach to the in vitro evaluation of potential for cytochrome P450 enzyme inhibition from herbals and other natural remedies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Variations in alkaloid content of herbal products containing goldenseal

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Different effects of traditional Chinese medicines containing similar herbal constituents on prednisolone pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Pharmacokinetic and pharmaceutic interaction between digoxin and Cremophor RH40.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Multivitamin supplements may affect warfarin anticoagulation in susceptible patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Dietary vitamin K influences intra-individual variability in anticoagulant response to warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Long-term Oral Anticoagulation Reduces Bone Mass in Patients with Previous Hemispheric Infarction and Nonrheumatic Atrial Fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Effect of vitamin A administered at Expanded Program on Immunization contacts on antibody response to oral polio vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Iron supplements: a common cause of drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Exaggerated levothyroxine malabsorption due to calcium carbonate supplementation in gastrointestinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Lack of Bioequivalence When Levofloxacin and Calcium‐Fortified Orange Juice Are Coadministered to Healthy Volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Lack of bioequivalence of gatifloxacin when coadministered with calcium-fortified orange juice in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Lack of bioequivalence of levofloxacin when coadministered with a mineral-fortified breakfast of juice and cereal

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Norfloxacin interaction with antacids and minerals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Lack of bioequivalence of ciprofloxacin when administered with calcium-fortified orange juice: a new twist on an old interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Spectroelectrochemical study of the interaction between antitumor drug daunomycin and DNA in the presence of antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Micronutrients and cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Neuroprotective effect of vitamin E supplementation in patients treated with cisplatin chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Antioxidant supplements block the response of HDL to simvastatin-niacin therapy in patients with coronary artery disease and low HDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Dietary supplement use in the Prostate Cancer Prevention Trial: implications for prevention trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Herbal composition PC-SPES for management of prostate cancer: identification of active principles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Ibuprofen arginate provides effective relief from postoperative dental pain with a more rapid onset of action than ibuprofen

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

A randomized, double-blind, placebo-controlled comparison of the analgesic efficacy, onset of action, and tolerability of ibuprofen arginate and ibuprofen in postoperative dental pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Inhibitory potential of herbal medicines on human cytochrome P450-mediated oxidation: properties of umbelliferous or citrus crude drugs and their relative prescriptions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Regulation of CYP3A4 expression in human hepatocytes by pharmaceuticals and natural products

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Drug interactions with St. John's Wort (Hypericum perforatum): a review of the clinical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

St John's wort (Hypericum perforatum): drug interactions and clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Effect of St John's wort on the pharmacokinetics of fexofenadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Unwanted pregnancy on self-medication with St John's wort despite hormonal contraception

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

The interaction between St John's wort and an oral contraceptive

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Interaction between cyclosporine and Hypericum perforatum (St. John's wort) after organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

St John's Wort supplements endanger the success of organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Alterations in cyclosporin A pharmacokinetics and metabolism during treatment with St John's wort in renal transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Impact of St John's wort treatment on the pharmacokinetics of tacrolimus and mycophenolic acid in renal transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Effect of St John's wort on imatinib mesylate pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Indinavir concentrations and St John's wort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Different effects of St John's wort on the pharmacokinetics of simvastatin and pravastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Mania in a patient receiving testosterone replacement postorchidectomy taking St John's wort and sertraline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Catalytic inhibition of human DNA topoisomerase IIalpha by hypericin, a naphthodianthrone from St. John's wort (Hypericum perforatum).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

No evidence for the involvement of interleukin 2 or the immunoglobulin heavy chain gene cluster in determining genetic susceptibility to multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Effects of garlic (Allium sativum L.) supplementation on cytochrome P450 2D6 and 3A4 activity in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

The effect of garlic supplements on the pharmacokinetics of saquinavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Effect of short-term administration of garlic supplements on single-dose ritonavir pharmacokinetics in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Panax ginseng: a systematic review of adverse effects and drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Siberian Ginseng (Eleutheroccus senticosus) Effects on CYP2D6 and CYP3A4 Activity in Normal Volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Inhibition of human cytochrome P450 activities by kava extract and kavalactones

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Coma from the health food store: interaction between kava and alprazolam

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Life-threatening parkinsonism induced by kava-kava

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Effects of the flavonoids biochanin A, morin, phloretin, and silymarin on P-glycoprotein-mediated transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Effect of milk thistle on the pharmacokinetics of indinavir in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Interaction of drugs and Chinese herbs: pharmacokinetic changes of tolbutamide and diazepam caused by extract of Angelica dahurica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Effects of Wu-chu-yu-tang and its component herbs on drug-metabolizing enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Effect of Glycyrrhiza glabra roots and glycyrrhizin on the glucuronidation in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Effects of the herbal extract PC-SPES on microtubule dynamics and paclitaxel-mediated prostate tumor growth inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Rhabdomyolysis due to red yeast rice (Monascus purpureus) in a renal transplant recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Interaction between warfarin and the herbal product quilinggao

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Pharmacokinetic interactions between warfarin and kangen-karyu, a Chinese traditional herbal medicine, and their synergistic action

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Potential interaction between warfarin and boldo-fenugreek

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

High prevalence of potentially hepatotoxic herbal supplement use in patients with fulminant hepatic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Identification of novel electrophilic metabolites of piper methysticum Forst (Kava).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Interaction between fibre and lovastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Structural requirements for the flavonoid-mediated modulation of glutathione S-transferase P1-1 and GS-X pump activity in MCF7 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Dietary flavonoids interact with trace metals and affect metallothionein level in human intestinal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Lethal quercetin-digoxin interaction in pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Effect of soy milk on warfarin efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Ipriflavone as an inhibitor of human cytochrome P450 enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Effect of daidzein on CYP1A2 activity and pharmacokinetics of theophylline in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

The effect of oral glucosamine sulfate on insulin sensitivity in human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Effects of oral prasterone (dehydroepiandrosterone) on single-dose pharmacokinetics of oral prednisone and cortisol suppression in normal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Carnitine is a naturally occurring inhibitor of thyroid hormone nuclear uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Fish oil interaction with warfarin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Randomized, placebo-controlled study of ethyl-eicosapentaenoic acid as supplemental treatment in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Herbal medicines for the treatment of rheumatoid arthritis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

Chinese herbs and warfarin potentiation by 'Danshen'

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F011542650502000133

10.1177/011542650502000133

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference